Oral anticoagulation with antiplatelet therapy after drug-eluting stent placement: adequate INR control must be demonstrated.
Murphy
P
P
D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D054855:Drug-Eluting Stents; D006801:Humans; D019934:International Normalized Ratio / Q000592:standards; D020521:Stroke / Q000517:prevention & control*
D000925:Anticoagulants; D001241:Aspirin